Targeting NFE2L1 signalling with small molecules to protect against Ferroptosis
Open Access
- 4 October 2025
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 130, 130425
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- Grantová Agentura České Republiky (GA22-16389S)
This publication has 31 references indexed in Scilit:
- Small-molecule activators of NRF1 transcriptional activity prevent protein aggregationBiomedicine & Pharmacotherapy, 2025
- Omaveloxolone attenuates the sepsis-induced cardiomyopathy via activating the nuclear factor erythroid 2-related factor 2International Immunopharmacology, 2022
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applicationsCell, 2022
- Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathwaysActa Pharmaceutica Sinica B, 2021
- Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2Clinical and Translational Medicine, 2021
- Non-Canonical Activation of NRF2: New Insights and Its Relevance to DiseaseCurrent Pathobiology Reports, 2017
- Lipid peroxidation in cell deathBiochemical and Biophysical Research Communications, 2017
- Mechanisms of ferroptosisCellular and Molecular Life Sciences, 2016
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012